Canary Medical Inc. - Pioneer of Implantable Smart Sensor Technology for Healthcare

📢 Key Milestones (2024–2026):
   In May 2024, the Canturio® Lumbar Cartridge received FDA Breakthrough Device designation, the fourth consecutive Canary product to ACHieve this status. In December 2025, Canary licensed VTT's MEMS pressure sensor and PMUT technologies to advance its cardiovascular program. In March 2026, Canary announced a strategic partnership with NanoHive Medical to jointly develop next-generation smart spinal cages integrating Canary's sensing technology with NanoHive's 3D printed implant design.

Company Profile (Updated April 2026)

Canary Medical Inc. is a medical technology company pioneering active implantAble platforms and AI-driven analytics, headquartered at 1450 Creekside Drive, Suite 400, Vancouver, British Columbia V6J 5B3, Canada. Founded in 2012 by Dr. Bill Hunter, an entrepreneur and physician with over 200 patents to his name, the company is focused on the development and commercialization of patented implantable sensor technology and a complementary data and analytics ecosystem.

Canary Medical's vision is to transform "dumb metal" implants into "smart" implanted medical devices that can self-report on function, activity, wear, complications, and patient outcomes for up to 20 years. The company's proprietary platform integrates sensors, memory, battery, and transmission technology into existing implantable devices, enabling 100% patient compliance with autonomous data collection and cloud transmission.

Development History:

- 2012: Founded in Vancouver, BC, by Dr. Bill Hunter with the vision that healthcare transformation requires reliable, cost-effective data from inside the body

- 2021.08: Received FDA De Novo classification grant and marketing authorization for the Canturio™ te tibial extension sensor, enabling Zimmer Biomet to launch Persona IQ® — the world's first and only smart knee implant for total knee replacement

- 2021: Commercial launch of Canturio™ te; sensor collects gait data at 25 observations per second continuously and 800 observations per second three times daily; powered by a 20-year pacemaker battery

- 2022.10: Appointed Lisa Suennen as President, Digital and Data Solutions; appointed Dr. Patrick Verta as Chief Medical Officer

- 2022.12: Launched Canary Quantiles™ Recovery Curves, the world's first orthopedic analytic module comparing individual patient recovery to aggregate population data from identical implantable sensors

- 2023: Won MedTech Breakthrough "Healthcare Analytics Innovation Award"; surpassed 500 million data points collected from smart knee implants

- 2024.02: Completed first-in-human feasibility trial of cardiac auscultation monitoring device in Paraguay, marking the first successful human implantation of a cardiac auscultation sensor

- 2024.05: Canturio® Lumbar Cartridge (canturio® lc) granted FDA Breakthrough Device designation for lumbar spinal fusion (L1–S1), representing Canary's first smart sensor application outside large joints

- 2025.12: Finalized licensing agreement with VTT (Finland) for MEMS Pressure Sensor and Piezoelectric Micromachined Ultrasonic Transducer (PMUT) technologies to enable development of implantable cardiovascular products

- 2026.03: Announced strategic partnership with NanoHive Medical to develop and commercialize smart spinal cages integrating Canary's active implant technology with NanoHive's Hive™ Soft Titanium® 3D printed spinal implant design

Core Mission: To improve healthcare outcomes through the collection, analysis, and monetization of data derived from proprietary smart implanted medical devices, reducing costs and enabling better clinical decisions.

Core Product Portfolio

Orthopedics — Smart Knee (canturio™ te)

- Canturio™ Tibial Extension (CTE): Proprietary implantable sensor integrated with Zimmer Biomet's Persona IQ® The Smart Knee®

- Technology: Embedded inertial measurement unit (IMU) with 3D gyroscopes and 3D accelerometers modeled after drone guidance systems; measures range of motion, step count, walking speed, and other gait metrics

- Data Collection: 25 observations per second continuously; 800 observations per second three times daily; data encrypted at rest and in transit; no personally identifiable data sent

- Battery Life: 20-year pacemaker-grade battery; collects data for at least 10 years

- Transmission: Autonomous wireless transmission via internet-connected base station within 6 feet of patient's sleeping area

- Canary Quantiles™ Recovery Curves: AI-driven analytics platform ranking patient recovery versus peer populations based on age, gender, and time since surgery

Spine — Smart Lumbar Cartridge (canturio™ lc)

- Canturio® Lumbar Cartridge: Designed for use with lumbar interbody fusion systems (L1–S1)

- Data: Objective kinematic data on fusion progression, segment mobility, and patient activity

- Clinical Goal: Early detection of clinically significant instability, partial fusion, and non-fusion

- Status: FDA Breakthrough Device designation granted May 2024

Cardiovascular Program

- Cardiac Auscultation Monitor: First-in-class implantable sensor for congestive heart failure management; first-in-human trial completed February 2024 in Paraguay

- MEMS Pressure Sensor & PMUT: Licensed from VTT (Finland) December 2025; ultra-low power sensors for implantable cardiovascular products

- Target Market: U.S. heart failure market projected at $70 billion annually by 2030

Data Management Platform

- Summatix™: Canary Medical's wholly owned data management subsidiary; aggregates, analyzes, and provides appropriate access to patient medical data

- Cloud Analytics: AI-driven interpretation of vibration patterns and gait metrics to identify potential joint problems (loosening, infection) before clinical symptoms appear

Strategic Partnerships

Zimmer Biomet (Long-Term Strategic Partner)

- Persona IQ®: World's first FDA-cleared smart knee implant combining Zimmer Biomet's Persona® knee with Canary's Canturio™ te sensor

- Expanded Partnership: Long-term agreement providing Zimmer Biomet proprietary use of Canary sensor technology across hip, shoulder, and other orthopedic applications

- Integration: Works with ZBEdge™ Connected Intelligence Suite and mymobility® with Apple Watch®

NanoHive Medical (Spine Partnership — 2026)

- Exclusive Partnership: Joint development of smart spinal cages integrating Canary's active implant technology with NanoHive's Hive™ Soft Titanium® 3D printed design

- Market: Global spinal fusion market estimated at $6–9 billion today, projected to grow to $13–16 billion over the next decade

VTT (Cardiovascular Technology — 2025)

- Licensing Agreement: VTT's MEMS Pressure Sensor and PMUT technologies for implantable cardiovascular products

- Focus: Chronic cardiovascular disease management through daily objective data

Regulatory Milestones

- FDA De Novo (2021): Canturio™ te tibial extension for Persona IQ smart knee — world's first FDA-cleared smart knee implant

- FDA Breakthrough Device Designations: Four consecutive products — smart knee, hip, shoulder, and spine lumbar cartridge

- CE Mark: European regulatory clearance for relevant products

Company Overview

Corporate Information

Legal Name: Canary Medical Inc.

Founded: 2012

Headquarters: 1450 Creekside Drive, Suite 400, Vancouver, British Columbia V6J 5B3, Canada

Phone: (760) 448-5066

Company Type: Privately held

Industry: Medical Technology / Digital Health / Implantable Sensors

Estimated Revenue: ~$7.6 million (2025)

Estimated Employees: ~64 (2025)

Website: www.canarymedical.com

Leadership Team

Founding Member, Chief Executive Officer & Chief Medical Officer: Dr. Bill Hunter, MD, MSc

- Physician, entrepreneur, and inventor with 200+ patents; previously founded Angiotech Pharmaceuticals; involved in invention of TAXUS® Drug-Eluting Stent, Zilver PTX Stent, and Quill barbed wound closure device; recipient of Manning Foundation Principal Award and Canadian Venture Capital Entrepreneur of the Year

Chief Medical Officer: Dr. Patrick Verta, MD, DVM, MS Stat. (appointed October 2022)

- Former VP of Medical Affairs at Edwards LifeSciences; previously CMO at Sunshine Heart and Neomend; holds doctorates in medicine and veterinary medicine from Paris, and a master's in biostatistics

Chief Surgical Officer: Dr. Fred D. Cushner, MD

- Former Chief Medical Officer of Canary Medical; orthopedic surgeon specializing in knee replacement and smart implant clinical applications

President, Digital and Data Solutions: Lisa Suennen (appointed October 2022)

- Former Senior Managing Director of Healthcare Investments at GE Ventures; former General Partner at Psilos Group; over 30 years of experience in healthcare as entrepreneur, venture capitalist, and strategy leader

Chief Financial Officer: Matteo Marchetta

Chief Communications Officer: Monica Kendrick

Investor & Media Contact: mkendrick@canarymedical.com

Competitive Landscape

- Boston Scientific: Cardiac and peripheral interventional devices

- Stryker: Orthopedic implants and medical devices

- Johnson & Johnson / DePuy Synthes: Orthopedic and neurosurgery devices

- BD (Becton Dickinson): Medical technology and diagnostics

- Smith+Nephew: Orthopedic reconstruction and advanced wound management

- Medtronic: Global leader in medical technology and implantable devices

- Abbott: Cardiovascular and diabetes care devices

- Zimmer Biomet: Strategic partner and competitor in orthopedic smart implants

- Convatec: Advanced wound care and ostomy products

- Terumo Corporation: Cardiac and vascular devices

2026 Strategic Outlook

- Smart Spine Commercialization: Advance Canturio® Lumbar Cartridge through FDA clearance and commercial launch with spine partners

- NanoHive Partnership: Develop and commercialize smart spinal cages combining sensing technology with advanced 3D printed titanium implants

- Cardiovascular Expansion: Leverage VTT sensor technologies to develop implantable cardiac monitoring products for congestive heart failure management

- Data Platform Growth: Expand Summatix analytics capabilities and AI-driven predictive algorithms across orthopedic, spine, and cardiovascular applications

- Global Partnerships: Deepen relationship with Zimmer Biomet and seek additional OEM partnerships for smart implant technology licensing

Contact Information

Global Headquarters

Address: 1450 Creekside Drive, Suite 400, Vancouver, British Columbia V6J 5B3, Canada

Phone: (760) 448-5066

Website: www.canarymedical.com

Email: admin@canarymedical.com

LinkedIn: Canary Medical on LinkedIn

Keywords: Canary Medical, canturio, smart knee, Persona IQ, Zimmer Biomet, implantable sensors, orthopedic sensors, spine sensors, lumbar cartridge, cardiovascular sensors, MEMS, PMUT, VTT, NanoHive Medical, Hive Soft Titanium, smart spinal cage, remote patient monitoring, digital health, medical data, Bill Hunter, Patrick Verta, Fred Cushner, Lisa Suennen, Monica Kendrick, Matteo Marchetta, Vancouver, Canada, FDA Breakthrough Device, FDA De Novo, Summatix, Canary Quantiles, Recovery Curves